Dilated cardiomyopathy (DCM) is a condition in which the heart gets enlarged and is not able to efficiently pump blood. The reduced heart function can affect the functioning of other organs such as lungs, liver, and kidney. The heart muscles begin to dilate (stretches), which result in thinning and increased area of the chamber, further it spreads to the right ventricle and atria’s. As the heart chambers dilate, heart muscles do not contract normally and not able to pump blood in a normal manner. Furthermore, heart becomes weak, which can ultimately lead to heart failure. Common symptoms of heart failure include fatigue, edema in ankles, legs, feet, veins in the neck and abdomen. There are various reasons for the cause of dilated cardiomyopathy such as viral infection, uncontrolled blood pressure, excessive amount of alcohol, and problem with the heart valve. There is no proper drug for the treatment of DCM, healthcare professionals use congestive heart failure drugs for treatment. Dilated cardiomyopathy majorly occurs in the age group of 20-60 years and rarely among children. It is easily diagnosed by normal chest X-ray and echocardiogram, and at times using cardiac MRI. There are certain implantable devices such as Implantable Cardioverter Defibrillator (ICD) and pacemaker which is implanted in the high risk patient body to maintain the proper rhythmic function of the heart and keeps the track of heart rate to avoid the chances of cardiac arrest. As per British Hear Foundation, in 2015, there are around 25,000 implants of pacemaker implanted every year in the UK. Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/514
© Copyright 2026 Paperzz
